U.S. Preventive Services Task Force
You Are Here: U.S. Preventive Services Task Force > Topic Index > Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions
Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions
This topic page summarizes the U.S. Preventive Services Task Force (USPSTF) recommendations on menopausal hormone therapy for the primary prevention of chronic conditions.
Current Recommendations
Release Date: October 2012- The USPSTF recommends against the use of combined estrogen and progestin for the prevention of chronic conditions in postmenopausal women.
Grade: D Recommendation. - The USPSTF recommends against the use of estrogen for the prevention of chronic conditions in postmenopausal women who have had a hysterectomy.
Grade: D Recommendation.
Supporting Documents
| Supporting Document | Related Items |
|---|---|
| Recommendation Statement (PDF File, 157 KB; PDF Help) | Clinical Summary (PDF File, 57 KB; PDF Help) |
| Consumer Fact Sheet (PDF File, 114 KB; PDF Help) | |
| Evidence Report (PDF File, 164 KB; PDF Help) | Evidence Synthesis (PDF File, 1 MB; PDF Help) |
Current as of October 2012
Internet Citation:
Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions, Topic Page. October 2012. U.S. Preventive Services Task Force. http://www.uspreventiveservicestaskforce.org/uspstf/uspspmho.htm
.png)
No hay comentarios:
Publicar un comentario